Epigenomic Profiling of Transcription Factors
Corresponding Organization :
Other organizations : Dana-Farber Cancer Institute, McGill University Health Centre, Harvard University, Dana-Farber Brigham Cancer Center, Coherus BioSciences (United States), Northwestern University, Mayo Clinic in Arizona, Kaiser Permanente Center for Health Research, University of Washington, Cedars-Sinai Medical Center, Cornell University, University Hospitals Seidman Cancer Center, Case Western Reserve University, McGill University
Variable analysis
- Antibodies used for ChIP-sequencing: AR (N-20; 6 μg, #sc-816, Santa Cruz Biotechnology), FOXA1 (4 μg, #ab23738, Abcam) and H3K27ac (1 μg, #C15410196, Diagenode)
- Genomic regions bound by AR, FOXA1 and H3K27ac
- The ChIP-sequencing protocol was performed at the Dana-Farber Cancer Institute using the protocol described previously in the referenced studies (32 and 64)
- No positive or negative controls were explicitly mentioned in the input information.
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!